Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,104
+$204 QoQ
Shares Held
90
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,518
of 1,603 holders
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FWL INVESTMENT MANAGEMENT, LLC holds $23,618,681 across 9 Drug Manufacturers - General names. NVS ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,864 | $19,027,759 | |
| 2 | AMGN |
Amgen Inc
|
4,439 | $1,607,450 | |
| 3 | ABBV |
AbbVie Inc.
|
5,047 | $1,270,027 | |
| 4 | AZN |
Astrazeneca PLC
|
4,601 | $872,441 | |
| 5 | JNJ |
Johnson & Johnson
|
2,809 | $713,401 | |
| 6 | MRK |
Merck & Co., Inc.
|
866 | $111,281 | |
| 7 | NVS |
Novartis AG
This page
|
90 | $14,104 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
13 | $1,642 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,104 | 90 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,900 | 91 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,687 | 34 | Shares | Sole | 2026-02-17 | |
| 2023-12-31 | $15,347 | 152 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||